Extended Remdesivir Infusion for Persistent COVID-19 Infection

Martinez, Mario A.; Chen, Ting Yi, Choi, Hosoon, Hwang, Munok, Navarathna, Dhammika, Hao, Linhue, Gale, Michael, Camus, Gregory, Ramirez, Hector E.; Jinadatha, Chetan

Martinez, Mario A.; Chen, Ting Yi, Choi, Hosoon, Hwang, Munok, Navarathna, Dhammika, Hao, Linhue, Gale, Michael, Camus, Gregory, Ramirez, Hector E.; Jinadatha, Chetan.

Open forum infectious diseases ; 2022.

Article in English | EuropePMC | ID: covidwho-1999094

ABSTRACT

ABSTRACT

Persistent SARS-CoV-2 infection patients are difficult to treat. Here, we report a case of 5-month persistent COVID-19 in an immunocompromised patient who was successfully treated with 30 consecutive days of Remdesivir. Prolonged remdesivir infusion with concurrent cycle threshold monitoring might provide a potential solution to cure these difficult patients.

Search on Google

XML

Collection: Databases of international organizations Database: EuropePMC Topics: Long Covid Language: English Journal: Open forum infectious diseases Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML